2020 ISPD实践建议:处方高质量、目标为导向的腹膜透析

2020-05-30 国际腹膜透析协会 Perit Dial Int . 2020 May;40(3):244-253.

2020年5月,国际腹膜透析协会(ISPD)发布了处方高质量、目标为导向的腹膜透析建议。该实践建议提出:透析处方应坚持“以患者为中心,以目标为导向”这一新的治疗理念。这需要腹膜

中文标题:

2020 ISPD实践建议:处方高质量、目标为导向的腹膜透析

英文标题:

International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis

发布机构:

国际腹膜透析协会

发布日期:

2020-05-30

简要介绍:

2020年5月,国际腹膜透析协会(ISPD)发布了处方高质量、目标为导向的腹膜透析建议。该实践建议提出:透析处方应坚持“以患者为中心,以目标为导向”这一新的治疗理念。这需要腹膜透析患者与照护团队共同进行讨论、决策SDM)。治疗目标包括:①允许腹膜透析患者达到自己的生活目标;②促进透析团队提供高质量的透析照护。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ISPD实践建议:处方高质量、目标为导向的腹膜透析.pdf)] GetToolGuiderByIdResponse(projectId=1, id=677541c0020380ee, title=2020 ISPD实践建议:处方高质量、目标为导向的腹膜透析, enTitle=International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis, guiderFrom=Perit Dial Int . 2020 May;40(3):244-253., authorId=0, author=, summary=2020年5月,国际腹膜透析协会(ISPD)发布了处方高质量、目标为导向的腹膜透析建议。该实践建议提出:透析处方应坚持“以患者为中心,以目标为导向”这一新的治疗理念。这需要腹膜, cover=https://img.medsci.cn/2021118/1610984827536_2020535.jpg, journalId=0, articlesId=null, associationId=165, associationName=国际腹膜透析协会, associationIntro=致力于推动腹膜透析的教育与科研。, copyright=0, guiderPublishedTime=Sat May 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年5月,国际腹膜透析协会(ISPD)发布了处方高质量、目标为导向的腹膜透析建议。该实践建议提出:透析处方应坚持&ldquo;以患者为中心,以目标为导向&rdquo;这一新的治疗理念。这需要腹膜透析患者与照护团队共同进行讨论、决策SDM)。治疗目标包括:①允许腹膜透析患者达到自己的生活目标;②促进透析团队提供高质量的透析照护。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2531, tagName=腹膜透析)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2531, guiderKeyword=腹膜透析, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6536, appHits=266, showAppHits=0, pcHits=1314, showPcHits=6270, likes=0, shares=18, comments=3, approvalStatus=1, publishedTime=Tue Jan 19 00:12:33 CST 2021, publishedTimeString=2020-05-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 18 23:47:13 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:38:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ISPD实践建议:处方高质量、目标为导向的腹膜透析.pdf)])
2020 ISPD实践建议:处方高质量、目标为导向的腹膜透析.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1055033, encodeId=2ce7105503347, content=已学习,很实用,有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac73101971, createdName=10123120, createdTime=Sun Sep 26 16:27:02 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945985, encodeId=95bd9459852f, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Mar 06 17:23:16 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920335, encodeId=adc89203351f, content=希望有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbibBPc7yJGvNVyBZX7IQnMAh7Kl4JeDQ6gmLfyXuDUicu0guY3ZdFUYbZm0rxmxbRu1U3838av4hg/132, createdBy=87825318957, createdName=xiaotingzi, createdTime=Wed Jan 27 16:57:36 CST 2021, time=2021-01-27, status=1, ipAttribution=)]
    2021-09-26 10123120

    已学习,很实用,有指导意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1055033, encodeId=2ce7105503347, content=已学习,很实用,有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac73101971, createdName=10123120, createdTime=Sun Sep 26 16:27:02 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945985, encodeId=95bd9459852f, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Mar 06 17:23:16 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920335, encodeId=adc89203351f, content=希望有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbibBPc7yJGvNVyBZX7IQnMAh7Kl4JeDQ6gmLfyXuDUicu0guY3ZdFUYbZm0rxmxbRu1U3838av4hg/132, createdBy=87825318957, createdName=xiaotingzi, createdTime=Wed Jan 27 16:57:36 CST 2021, time=2021-01-27, status=1, ipAttribution=)]
    2021-03-06 jyzxjiangqin

    好文章!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1055033, encodeId=2ce7105503347, content=已学习,很实用,有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac73101971, createdName=10123120, createdTime=Sun Sep 26 16:27:02 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945985, encodeId=95bd9459852f, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Mar 06 17:23:16 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920335, encodeId=adc89203351f, content=希望有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbibBPc7yJGvNVyBZX7IQnMAh7Kl4JeDQ6gmLfyXuDUicu0guY3ZdFUYbZm0rxmxbRu1U3838av4hg/132, createdBy=87825318957, createdName=xiaotingzi, createdTime=Wed Jan 27 16:57:36 CST 2021, time=2021-01-27, status=1, ipAttribution=)]
    2021-01-27 xiaotingzi

    希望有中文版

    0

拓展阅读

2009 ISPD腹膜透析时长及包裹性腹膜硬化症意见书

国际腹膜透析协会(ISPD,International Society for peritoneal dialysis) · 2009-11-01

2010 ISPD腹膜透析相关感染更新建议

国际腹膜透析协会(ISPD,International Society for peritoneal dialysis) · 2010-07-01

2010RA临床实践指南:腹膜透析

英国肾脏病协会(RA,The Renal Association) · 2010-07-30

腹膜透析标准操作规程(2010年出版)

中华医学会肾脏病学分会 · 2010-11-01

2011CSN临床指南和建议:腹膜透析充分性

加拿大肾脏病学会(CSN,CANADIAN SOCIETY OF NEPHROLOGY) · 2011-03-01

2011NICE慢性肾脏病第5期的腹膜透析治疗指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-07-01